The U.S. Food and Drug Administration today warned health care professionals about the risk of serious liver injury associated with the use of the anti-thyroid drug propylthiouracil (PTU) for the treatment of Graves’ disease.
Read the original here:
FDA Warns About Serious Liver Injury Associated With Anti-Thyroid Drug